Inventor · disambiguated record
Guoquan Wang
Also filed as: WANG GUOQUAN
18 granted patents·3 pending applications·263 citations·filing 2004–2022
93Inventor score
Files withLEWIS AND CLARK PHARMACEUTICALS INC4PGX HEALTH LLC4WANG GUOQUAN4PGXHEALTH LLC3ADENOSINE THERAPEUTICS LLC2
Top patents by PatentIndex Score
21 records- 0197US7579348B2Derivatives of 8-substituted xanthinesPGXHEALTH LLC·Filed 2006·Granted Aug 25, 2009·124 cites·47 claims
- 0294US7598379B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 6, 2009·14 cites·10 claims
- 0392US9067963B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2013·Granted Jun 30, 2015·30 cites·32 claims
- 0490US7618962B2Pyrazolyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Nov 17, 2009·16 cites·59 claims
- 0589US7732455B2Substituted 8-heteroaryl xanthinesPGX HEALTH LLC·Filed 2007·Granted Jun 8, 2010·12 cites·102 claims
- 0689US7601723B2Pyridyl substituted xanthinesPGX HEALTH LLC·Filed 2006·Granted Oct 13, 2009·17 cites·58 claims
- 0787US7884100B2Substituted 8-[6-amino-3-pyridyl]xanthinesPGXHEALTH LLC·Filed 2007·Granted Feb 8, 2011·9 cites·48 claims
- 0887US7342006B2Substituted 8-heteroaryl xanthinesADENOSINE THERAPEUTICS LLC·Filed 2004·Granted Mar 11, 2008·27 cites·55 claims
- 0985US7875608B2Substituted 8-[6-amino-3pyridyl]xanthinesTHOMPSON ROBERT D·Filed 2008·Granted Jan 25, 2011·9 cites·24 claims
- 1075US8153628B2Pyrazolyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 10, 2012·2 cites·40 claims
- 1169US9822141B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·28 claims
- 1268US8420813B2Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthinesWANG GUOQUAN·Filed 2009·Granted Apr 16, 2013·0 cites·1 claims
- 1366US8193200B2Antagonists of A2B adenosine receptors for treatment of inflammatory bowel diseaseSITARAMAN SHANTHI V·Filed 2007·Granted Jun 5, 2012·2 cites·2 claims
- 1462US2024247257A1System and methods for insertion and editing of large nucleic acid fragmentsUNIV WUHAN·Filed 2022·Application pending·0 cites
- 1560US8501941B2Methods for the synthesis of unsymmetrical cycloakyl substituted xanthinesWANG GUOQUAN·Filed 2012·Granted Aug 6, 2013·0 cites·9 claims
- 1656US7470697B2Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2B adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2007·Granted Dec 30, 2008·0 cites·396 claims
- 1753US8349848B2Pyrrolo[3,2-D]pyrimidines that are selective antagonists of A2B adenosine receptorsDOGWOOF PHARMACEUTICALS INC·Filed 2008·Granted Jan 8, 2013·0 cites·18 claims
- 1851US8258142B2Substituted 8-[6-amino-3-pyridyl]xanthinesWANG GUOQUAN·Filed 2010·Granted Sep 4, 2012·0 cites·5 claims
- 1950US2019077824A1N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2048US2010273780A1Substituted 8-heteroaryl xanthinesPGXHEALTH LLC·Filed 2010·Application pending·0 cites
- 2140US9593118B2Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2016·Granted Mar 14, 2017·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Guoquan Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →